Hawthorn Berry 565 mg

Hawthorn Berry 565 mg

Swanson4.7 (6,643 ratings)
Format:Capsule Quantity: 250 Capsule(s) · 250 servings
Goals
$15.79 $0.06 per serving

Product analysis

63 out of 100

Hawthorn Berry 565 mg offers a focused hawthorn supplement at a low cost per serving. Findings from particular extracts in people with heart failure do not establish routine cardiovascular benefits from this preparation.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The hawthorn preparation is unspecified. Its quality and similarity to particular standardized extracts therefore remain uncertain.

Ingredient Transparency63

The hawthorn amount is disclosed, so the serving quantity can be checked. Its missing form prevents a clear comparison with specific standardized extracts.

Value For Money100

The labeled hawthorn serving is inexpensive. Its low price does not resolve uncertainty about preparation-specific benefits.

Customer Satisfaction89

Customer ratings are very positive across a large number of reviews. That broad satisfaction picture does not establish a cardiovascular benefit.

Product Focus73

The single-ingredient formula has a narrow heart-related purpose. Findings for particular extracts in treated heart failure do not show routine benefit from ordinary hawthorn berry.

Format
Capsule
Container
250 Capsule(s)
Per serving
$0.06
Customer rating
4.7 · 6,643 ratings
Report analysis

Goals

Heart Health
Impact
High effect
A+ Ingredient FitD- PathwaysC+ EvidenceA+ Formulation Logic
Study evidence
Hawthorn Supportive 27 studies
Impact
Highest effect
A+ Ingredient FitD+ PathwaysB+ EvidenceA+ Formulation Logic
Hawthorn · 565 mg
Study evidence
Hawthorn Supportive 28 studies

Ingredients

IngredientAmount per servingScore
Hawthorn
565 mg 52
Adults 18–50
Report overview
Hawthorn · 565 mg OverallScore52
F Composition And Label DisclosureA+ Commercial Price And Usability
Hawthorn Berry 565 mg provides 565 mg of hawthorn per serving at a low selected-serving cost. The available information does not specify a marker concentration or species.
How this ingredient is rated

Composition and Label Disclosure29

A marker concentration or extract ratio is not available. The hawthorn species is not available in the information.
Marker and Preparation Disclosure
A marker concentration or extract ratio is not available.
Species Name Disclosure
The hawthorn species is not available in the information.

Composition and Label Disclosure

No separate composition or label disclosure rule applies here.

Commercial Price and Usability100

The selected serving cost is low.
Commercial Price per Labeled Serving
The cost per selected serving is low.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
    Wyss C; Gündling PW; Kostev K · Scientific reports · 2024
    Cohort study9,100 participantsCardiovascular Support forHawthorn
  2. Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
    Szikora Z; Mátyus RO; Szabó BV; Csupor D; Tóth B · Pharmaceuticals (Basel, Switzerland) · 2025
    Meta-analysis428 participants6 studies pooledCardiovascular Support Heart Health forHawthorn
  3. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
    Degenring FH; Suter A; Weber M; Saller R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2003
    Randomized trial143 participantsCardiovascular Support forHawthorn
  4. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
    Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J · Fortschritte der Medizin · 1996
    Randomized trial136 participantsCardiovascular Support forHawthorn
  5. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
    Habs M · Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine · 2005
    Cohort study952 participantsCardiovascular Support forHawthorn
  6. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
    Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK · Arzneimittel-Forschung · 2001
    Randomized trial88 participantsHeart Health forHawthorn
  7. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
    Pittler MH; Schmidt K; Ernst E · The American journal of medicine · 2003
    Meta-analysis632 participants13 studies pooledHeart Health forHawthorn
  8. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
    Zapfe jun G · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2002
    Randomized trial40 participantsHeart Health forHawthorn
  9. Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.
    Eggeling T; Regitz-Zagrosek V; Zimmermann A; Burkart M · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Meta-analysis687 participants10 studies pooledHeart Health forHawthorn